Compare Chipotle Mexican Grill, Inc. (CMG) vs DexCom, Inc. (DXCM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Chipotle Mexican Grill, Inc. vs DexCom, Inc. — how do they compare? Chipotle Mexican Grill, Inc. trades at $32.63 (market cap $41.30B), while DexCom, Inc. trades at $91.21 (market cap $34.26B). The key difference: Chipotle Mexican Grill, Inc. is the larger of the two by market cap, and DexCom, Inc. is trading nearer its 52-week high, Chipotle Mexican Grill, Inc. nearer its low. Which is the better fit depends on your goals.
| CMG | DXCM | |
|---|---|---|
Market Cap | $41.30B | $34.26B |
Sector | Consumer Cyclical | Health |
52-Week High | $44.04 | $91.48 |
52-Week Low | $28.17 | $54.84 |
Enterprise Value | $46.05B | $33.72B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CMG trades at $32.62, up 1.99% today, with a bearish technical signal from moving averages but oversold RSI levels. The company reported strong Q2 2026 earnings, beating EPS estimates with $0.33 actual vs. $0.32 expected, and continues expansion into Saudi Arabia. Revenue grew to $11.93B in 2025, though net income margin dipped to 11.42% from 13.55% in 2024.
Outlook remains positive with a $42.17 consensus price target and 70% buy ratings, but risks include food safety concerns from recent salmonella and cyclospora outbreaks, margin compression, and negative net cash flow trends. International growth and buybacks support upside, yet consumer caution and cost pressures pose headwinds.
DXCM trades at $91.48, up 2.18% today, near its 52-week high. The stock shows strong bullish momentum with consistent earnings beats, including Q2 2026 EPS of $0.70 versus $0.61 expected. Revenue growth accelerated to $4.66 billion in 2025, with net income margins improving to 17.93%. Technical indicators signal bullish trends, supported by moving averages, while RSI levels indicate potential overbought conditions. Recent news highlights raised 2026 guidance driven by G7 system adoption and international expansion.
Outlook remains positive due to robust fundamentals and analyst consensus, but risks include premium valuation and competitive pressures. The stock offers growth potential from expanding CGM market share, though investors should monitor margin sustainability and litigation concerns. With 80% buy ratings and a consensus price target of $88.65, near-term upside may be limited, but long-term growth drivers are intact.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Chipotle Mexican Grill, Inc.
Chipotle Mexican Grill is the largest fast-casual chain restaurant in the United States, with systemwide sales of $7.5 billion in 2021. The Mexican concept is entirely company-owned, with a footprint of more than 3,000 stores, heavily indexed to the United States (though the firm maintains a small presence in Canada, the U.K., France, and Germany). Chipotle sells burritos, burrito bowls, tacos, quesadillas, and beverages, with a selling proposition built around competitive prices, high-quality food sourcing, speed of service, and convenience. The company generates its revenue entirely from restaurant sales and delivery fees.
Read more on CMG →About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →
